Day: November 17, 2022
ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) —
MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today reported that the U.S. Food and Drug Administration announced the approval of the Biologics License Application (BLA) for teplizumab, an anti-CD3 monoclonal antibody that was previously developed by MacroGenics. Teplizumab was acquired by Provention Bio, Inc. in May 2018 pursuant to an asset purchase agreement.
“We are very pleased to see the culmination of years of effort by Provention, MacroGenics, and tireless champions in academia and government, with the achievement of the approval of teplizumab,” said Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. “We applaud this outcome, which represents...
Toll Brothers Apartment Living® Tops Out Broad & Noble, a New Luxury High-Rise Apartment Community Coming to Philadelphia
Written by Customer Service on . Posted in Public Companies.
The 18-story, 344-unit luxury mixed-use apartment community totals more than 282k square feet and includes more than 10k square feet of ground-floor retail spaceBroad & Noble Topping-Out Celebration in Philadelphia, PA
Philadelphia City Council member Mark Squilla joins members of the Broad & Noble development team, including Toll Brothers Apartment Living, Sundance Bay, and Clemens Construction Company, for a ceremonial beam-signing before the beam was hoisted to the top of the construction site.Broad & Noble Topping-Out Celebration in Philadelphia, PA
Members of the Ironworkers Local Union 401 take part in a ceremonial beam-signing before the beam was hoisted to the top of the construction site.PHILADELPHIA, Nov. 17, 2022 (GLOBE NEWSWIRE) — Toll Brothers Apartment Living®, the rental subsidiary of Toll Brothers,...
ToughBuilt Industries Announces Closing of $7.5 Million Private Placement Priced At-The-Market under Nasdaq Rules
Written by Customer Service on . Posted in Public Companies.
IRVINE, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced that it has closed its previously announced private placement with several institutional investors for the issuance and sale of 2,619,911 shares of common stock (or pre-funded warrants in lieu thereof) and preferred investment options to purchase up to 10,619,911 shares of common stock at an offering price of $2.862692 per share (or pre-funded warrant) and accompanying preferred investment options, priced at-the-market under Nasdaq rules. The preferred investment options are exercisable immediately upon issuance, have a term of three years and an exercise price of $2.356 per share.
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
The gross proceeds...
ToughBuilt Industries Announces $7.5 Million Private Placement Priced At-The-Market under Nasdaq Rules
Written by Customer Service on . Posted in Public Companies.
LAKE FOREST, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced that it has entered into definitive agreements with several institutional investors for the issuance and sale of 2,619,911 shares of common stock (or pre-funded warrants in lieu thereof) and preferred investment options to purchase up to 10,619,911 shares of common stock at an offering price of $2.862692 per share (or pre-funded warrant) and accompanying preferred investment options, in a private placement priced at-the-market under Nasdaq rules. The preferred investment options are exercisable immediately upon issuance, have a term of three years and an exercise price of $2.356 per share. The private placement is expected to close on or about November 17, 2022, subject to the...
Transocean Acquires Interest in High Specification Ultra-Deepwater Newbuild Drillship
Written by Customer Service on . Posted in Public Companies.
STEINHAUSEN, Switzerland, Nov. 17, 2022 (GLOBE NEWSWIRE) — Transocean Ltd. (“Transocean”) today announced that one of its subsidiaries, together with Perestroika A.S. and funds managed by Lime Rock Management L.P., have formed a joint venture, Liquila Ventures Ltd. (“Liquila Ventures”).
Liquila Ventures agreed with Daewoo Shipbuilding & Marine Engineering Co., Ltd. (“DSME”), to purchase Hull 3623, the ultra-deepwater newbuild drillship formerly known as West Aquila, for approximately $200 million.
Hull 3623 is a high specification, 1400 short-ton hookload ultra-deepwater drillship. This seventh-generation dual-activity drillship will have a large deck space, high load capacities, and will be dual-stack ready.
Transocean has made a $15 million noncontrolling investment in Liquila Ventures and maintains the exclusive right to...
Goldstar Acquires Claims in Québec
Written by Customer Service on . Posted in Mergers And Acquisitions.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES
MONTRÉAL, Nov. 17, 2022 (GLOBE NEWSWIRE) — Goldstar Minerals Inc. (“Goldstar” or the “Corporation”) (TSX-V: GDM) is pleased to announce that it has entered into a Purchase and Sale Agreement (the “Agreement”), effective October 27, 2022, with Jean Bernard (the “Owner”) with respect to a property (the “Property”), consisting of 2 claims and covering an area of approximately 120 hectares (1.2 km2).
The Property is located in the Montérégie region of southern Québec.
The Agreement provides for the acquisition of an undivided interest of 100% in the Property by paying the Owner $25,000 plus applicable taxes and issuing 500,000 common shares of the Corporation. Upon commercial production, Goldstar will issue an additional 1,000,000 common shares of the Corporation.
Closing...
Post Holdings Reports Results for the Fourth Quarter and Fiscal Year 2022
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
ST. LOUIS, Nov. 17, 2022 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the fourth fiscal quarter and fiscal year ended September 30, 2022.
Highlights:Fourth quarter net sales of $1.6 billion; operating profit of $131.9 million; net earnings from continuing operations of $83.9 million and Adjusted EBITDA of $279.7 million
Fiscal year net sales of $5.9 billion; operating profit of $415.6 million; net earnings from continuing operations of $735.0 million and Adjusted EBITDA of $963.5 million
Generated $384.2 million in cash from continuing operations in fiscal year 2022
Fiscal year 2023 Adjusted EBITDA (non-GAAP) expected to range between $990-$1,040 millionBasis of Presentation
On March 10, 2022, Post’s distribution to its shareholders of 80.1% of its...
BellRing Brands Reports Results for the Fourth Quarter and Fiscal Year 2022
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
ST. LOUIS, Nov. 17, 2022 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global convenient nutrition category, today reported results for the fourth fiscal quarter and fiscal year ended September 30, 2022.
Highlights:Fourth quarter net sales of $379.2 million, operating profit of $61.1 million; net earnings available to common stockholders of $33.7 million and Adjusted EBITDA of $79.9 million
Fiscal year net sales of $1,371.5 million, operating profit of $212.4 million; net earnings available to common stockholders of $82.3 million and Adjusted EBITDA of $271.4 million
Fiscal year 2023 net sales and Adjusted EBITDA expected to range between $1.56-$1.64 billion and $300-$325 million, respectivelyFourth Quarter Operating Results
Net sales were $379.2 million, an increase of...
Acuity Brands Announces Upcoming Retirement of Dominic J. Pileggi and Ray M. Robinson from the Board of Directors
Written by Customer Service on . Posted in Public Companies.
Atlanta, Nov. 17, 2022 (GLOBE NEWSWIRE) —
The Board of Directors (the “Board”) of Acuity Brands, Inc. (NYSE: AYI) (the “Company”) announced today the retirement of Dominic J. Pileggi and Ray M. Robinson from the Board at the end of their current terms, effective January 25, 2023. As a result, Mr. Pileggi and Mr. Robinson will not stand for reelection at the Company’s upcoming 2023 Annual Meeting.
“On behalf of the Board, I want to thank Dominic and Ray for their outstanding leadership, distinguished service, and valuable counsel. Their guidance has helped shape the strategy and success of our Company,” said Neil M. Ashe, Chairman, President, and Chief Executive Officer, of Acuity Brands. “We are grateful for their expertise and contributions on our Board throughout their respective tenures. We wish them the very best following...
Theralase ® Closes Private Placement Equity Financing
Written by Customer Service on . Posted in Public Companies.
TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations, used to destroy various cancers, bacteria and viruses, safely and effectively, is pleased to announce that it has closed a non-brokered private placement offering (“Offering”) of units (“Units”). On closing, the Corporation issued an aggregate of 1,000,000 Units at a price of $0.25 per Unit for aggregate gross proceeds of approximately $250,000.
Each Unit consisted of one common share of the Company (“Common Share”) and one common share purchase warrant (“Warrant”). Each Warrant entitles the holder to acquire an additional Common...